Hosts David and Gina explore the unexpected origins of blockbuster diabetes and weight-loss drugs like Ozempic and Wegovy ...
Michigan Attorney General Dana Nessel's office is asking the court to overturn two previous rulings and allow an investigation into Eli Lilly and Co.
The Michigan Supreme Court will decide whether to overturn past precedent to clear the way for an attorney general probe into ...
Mediafeed on MSN
Thinking about GLP-1 for weight loss? Here’s the full scoop
This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...
A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...
In recent years, effective obesity treatments like Ozempic and Mounjaro have changed lives. These drugs mimic the effects of ...
Hospitalized patients with diabetes require specialized management to reduce readmission rates and complications. Newer ...
An innovative ‘smart insulin’ may offer people living with type 1 diabetes improved treatment options to regulate blood glucose levels. This is the discovery of researchers at Indiana University, who ...
Its hard to imagine GLP-1 drugs making more of an impact on our collective health than they already have. A new generation of these injectable medications has transformed treatment possibilities for ...
LOS ANGELES — Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other ...
Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results